Vitagenum sp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2013-10-18
Share capital
216,700.00 PLN
Activity description

Vitagenum is a genetic laboratory in Lublin offering DNA and nutrigenetic testing. Its tests explore genetic predispositions related to metabolism, diet, health, fitness, food intolerances and children's talents, with reports providing recommendations for diet and lifestyle. The company has operated its own DNA laboratory since 2013.

Registered address
Dobrzańskiego 3, 20-262 Lublin, Poland
Email
Phone
Social media
Electronic delivery address
AE:PL-97836-29608-SAFBA-24

Financials

Revenue history (in k)

From the notes

Profit allocationLoss to be covered
Management board pay$54,244

Filing timeliness

3 of 6 financial statements were filed late (the longest delay 230 days for 2020).

  • 202502/07/2026
  • 202402/07/2025
  • 202327/06/2024
  • 202218/07/2023
  • 202130/09/2022
  • 202002/06/2022
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Division · Scientific research and development1,423 / 1,943
Top 73%
City · Lublin4,137 / 4,828
Top 86%
Voivodeship · Lubelskie8,941 / 10,176
Top 88%
Country · Poland260,253 / 297,266
Top 88%

Results vs industry

Revenue
This companyUSD 9.38kMedianUSD 56.72kAverageUSD 2.72m
Net profit
This companyUSD -168.44kMedianUSD -1.27kAverageUSD -93.01k
Operating costs
This companyUSD 177.37kMedianUSD 66.48kAverageUSD 2.68m
Assets
This companyUSD 543.12kMedianUSD 134.71kAverageUSD 3.04m

Offer

Websites

  • vitagenum.plNutrigenetyka i badania genetyczne DNA | VITAGENUM
    Google AnalyticsGoogle Tag ManagerLiteSpeed

Public procurement

1 tender recorded as contractor, with a total value of $49.

SubjectAmount
Purchase of laboratory diagnostic services for the detection of SARS-CoV-2 among employees of Oddział ZUS w Lublin
$49

Trademarks

The company currently holds no active trademarks with the Polish Patent Office. 2 applications are pending. The first mark was filed in 2026.

MarkNumberClassesStatusProtected until
4seasons.care Z.6035565, 35Application pending –
Nervella (word)Z.6035575Application pending –
MarkProtected until
4seasons.care –
Nervella (word)–

Authorized Representatives

Tomasz Zdzisław Czernecki age 50 – Vice President of the Management Board
Maciej Jacek Maniecki age 64 – President

Manner of representation

In the case of a one-person or two-person management board, each member of the management board is entitled to make declarations of will and sign on behalf of the company independently. In the case of a three-person management board, the President of the Management Board independently or two Vice-Presidents acting jointly are entitled to make declarations of will and sign on behalf of the company.

Ownership

OwnerSharesShare valueStake
1,064$28,741.2249.1001%
Napco S.A. R. L.
943$25,472.7243.5164%
Others
160$4,321.997.3835%

Beneficial owners

No beneficial owners recorded for the company Vitagenum.

Subsidiaries

NameStake
Nexbio sp. z o.o.
39.302%

Bank accounts

Registered as a VAT taxpayer on 2013-11-09.

  • mBank
    25 1140 1094 0000 4179 3200 1001
  • mBank
    68 1140 1094 0000 4179 3200 1003
  • mBank
    95 1140 1094 0000 4179 3200 1002

Debt

No entries in the National Debtors Register (KRZ).

Public aid

6 public aid cases recorded, with a total value of $36,837.

PurposeGross amount
Other crisis aid
$4,241
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,307
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,198

European Funds

ProjectEU co-financing
R&D work on developing a new technology for joining amplicons and reading the sequence of the DNA segment thus obtained
$261K

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Anchem Laboratorium Analiz Medycznych Nzoz sp. z o.o.
Novazym sp. z o.o.
Centrum Medycyny Klinicznej Dimedical sp. z o.o.
Alldiagnostica sp. z o.o.
Diagnostyka Obrazowa Bydgoszcz sp. z o.o.
Info-Pat sp. z o.o.
Vitaimmun sp. z o.o.
Testdna Ekspertyzy sp. z o.o. + limited partnership
Inngen S.A.
Neobiolab sp. z o.o.

Change history

DateEvent
2022-02-18Share capital increase
2019-01-23Share capital increase
2017-05-22Share capital increase
2017-05-22PKD change
2015-10-19Share capital increase

FAQ

Last updated: 2026-07-04